Nicole Thielens

Nicole Thielens

orcid

Research Focus & Metrics

Academic Career Length

48Years (1979-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Molecular Immunology
Verified
Journal Article
Open access
NTNicole Thielens
Nicole Thielens
FTFrancesco Tedesco
Francesco Tedesco
SBSuzanne S. Bohlson
Suzanne S. Bohlson
CGChristine Gaboriaud
Christine Gaboriaud
ATAndrea J. Tenner
Andrea J. Tenner
Originally discovered as part of C1, the initiation component of the classical complement pathway, it is now appreciated that C1q regulates a variety of cellular processes independent of complement activation. C1q is a complex glycoprotein assembled from 18 polypeptide chains, with a C-terminal globular head region that mediates recognition of diverse molecular structures, and an N-terminal collagen-like tail that mediates immune effector mechanisms. C1q mediates a variety of immunoregulatory functions considered important in the prevention of autoimmunity such as the enhancement of phagocytosis, regulation of cytokine production by antigen presenting cells, and subsequent alteration in T-lymphocyte maturation. Furthermore, recent advances indicate additional roles for C1q in diverse physiologic and pathologic processes including pregnancy, tissue repair, and cancer. Finally, C1q is emerging as a critical component of neuronal network refinement and homeostatic regulation within the central nervous system. This review summarizes the classical functions of C1q and reviews novel discoveries within the field.

1 July 2004 in Trends in Immunology
Verified
Journal Article
Closed access
CGChristine Gaboriaud
Christine Gaboriaud
NTNicole Thielens
Nicole Thielens
LGLynn A Gregory
Lynn A Gregory
VRVéronique Rossi
Véronique Rossi
JFJuan C Fontecilla-Camps
Juan C Fontecilla-Camps
GAGérard J Arlaud
Gérard J Arlaud

18 September 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
CMCecile Morlot
Cecile Morlot
NTNicole Thielens
Nicole Thielens
RRRaimond B. G. Ravelli
Raimond B. G. Ravelli
WHWieger Hemrika
Wieger Hemrika
RRRoland A. Romijn
Roland A. Romijn
AMAndrew Aloysius Mccarthy
Andrew Aloysius Mccarthy
Slits are large multidomain leucine-rich repeat (LRR)-containing proteins that provide crucial guidance cues in neuronal and vascular development. More recently, Slits have been implicated in heart morphogenesis, angiogenesis, and tumor metastasis. Slits are ligands for the Robo (Roundabout) receptors, which belong to the Ig superfamily of transmembrane signaling molecules. The Slit-Robo interaction is mediated by the second LRR domain of Slit and the two N-terminal Ig domains of Robo, but the molecular details of this interaction and how it induces signaling remain unclear. Here we describe the crystal structures of the second LRR domain of human Slit2 (Slit2 D2), the first two Ig domains of its receptor Robo1 (Ig1–2), and the minimal complex between these proteins (Slit2 D2-Robo1 Ig1). Slit2 D2 binds with its concave surface to the side of Ig1 with electrostatic and hydrophobic contact regions mediated by residues that are conserved in other family members. Surface plasmon resonance experiments and a mutational analysis of the interface confirm that Ig1 is the primary domain for binding Slit2. These structures provide molecular insight into Slit-Robo complex formation and will be important for the development of novel cancer therapeutics.

4 May 2018 in Science
Verified
Journal Article
Open access
PDF file
GLGuang Sheng Ling
Guang Sheng Ling
GCGreg Crawford
Greg Crawford
NBNorzawani Buang
Norzawani Buang
IBIstvan Bartok
Istvan Bartok
KTKunyuan Tian
Kunyuan Tian
MBMarina Botto
Marina Botto
Complement is a CD8 + T cell metabolic rheostat: Systemic lupus erythematosus (SLE) is associated with deficiencies in the complement protein C1q. Although C1q plays a role in the clearance of apoptotic cells, there are several redundant clearance pathways. Disruption of one pathway does not lead to an autoimmune defect. In a chronic graft-versus-host disease model of SLE, Ling et al. show that C1q dampens CD8 + T cell responses to self-antigens. C1q modulates metabolism through the mitochondrial cell-surface protein p32/gC1qR. The lack of C1q during a viral infection also enhances CD8 + T cell responses. Thus, C1q plays a role as a “metabolic rheostat” for effector CD8 + T cells. Science , this issue p. 558

30 March 2012 in Circulation Research
Verified
Journal Article
Closed access
PDF file
ABAlexis Broisat
Alexis Broisat
Sophie HernotSophie Hernot
Sophie Hernot
JTJakub Toczek
Jakub Toczek
JVJens De Vos
Jens De Vos
LRLaurent M. Riou
Laurent M. Riou
Nick DevoogdtNick Devoogdt
Nick Devoogdt
Rationale:: A noninvasive tool allowing the detection of vulnerable atherosclerotic plaques is highly needed. By combining nanomolar affinities and fast blood clearance, nanobodies represent potential radiotracers for cardiovascular molecular imaging. Vascular cell adhesion molecule-1 (VCAM1) constitutes a relevant target for molecular imaging of atherosclerotic lesions. Objective:: We aimed to generate, radiolabel, and evaluate anti-VCAM1 nanobodies for noninvasive detection of atherosclerotic lesions. Methods and Results:: Ten anti-VCAM1 nanobodies were generated, radiolabeled with technetium-99m, and screened in vitro on mouse and human recombinant VCAM1 proteins and endothelial cells and in vivo in apolipoprotein E–deficient (ApoE −/− ) mice. A nontargeting control nanobody was used in all experiments to demonstrate specificity. All nanobodies displayed nanomolar affinities for murine VCAM1. Flow cytometry analyses using human human umbilical vein endothelial cells indicated murine and human VCAM1 cross-reactivity for 6 of 10 nanobodies. The lead compound cAbVCAM1-5 was cross-reactive for human VCAM1 and exhibited high lesion-to-control (4.95±0.85), lesion-to-heart (8.30±1.11), and lesion-to-blood ratios (4.32±0.48) ( P <0.05 versus control C57Bl/6J mice). Aortic arch atherosclerotic lesions of ApoE −/− mice were successfully identified by single-photon emission computed tomography imaging. 99m Tc-cAbVCAM1-5 binding specificity was demonstrated by in vivo competition experiments. Autoradiography and immunohistochemistry further confirmed cAbVCAM1-5 uptake in VCAM1-positive lesions. Conclusions:: The 99m Tc-labeled, anti-VCAM1 nanobody cAbVCAM1-5 allowed noninvasive detection of VCAM1 expression and displayed mouse and human cross-reactivity. Therefore, this study demonstrates the potential of nanobodies as a new class of radiotracers for cardiovascular applications. The nanobody technology might evolve into an important research tool for targeted imaging of atherosclerotic lesions and has the potential for fast clinical translation.

11 January 2007 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
VGVirginie Garlatti
Virginie Garlatti
NBNicolas Belloy
Nicolas Belloy
LMLydie Martin
Lydie Martin
MLMonique Lacroix
Monique Lacroix
MMMisao Matsushita
Misao Matsushita
CGChristine Gaboriaud
Christine Gaboriaud
Innate immunity relies critically upon the ability of a few pattern recognition molecules to sense molecular markers on pathogens, but little is known about these interactions at the atomic level. Human L‐ and H‐ficolins are soluble oligomeric defence proteins with lectin‐like activity, assembled from collagen fibers prolonged by fibrinogen‐like recognition domains. The X‐ray structures of their trimeric recognition domains, alone and in complex with various ligands, have been solved to resolutions up to 1.95 and 1.7 Å, respectively. Both domains have three‐lobed structures with clefts separating the distal parts of the protomers. Ca2+ ions are found at sites homologous to those described for tachylectin 5A (TL5A), an invertebrate lectin. Outer binding sites (S1) homologous to the GlcNAc‐binding pocket of TL5A are present in the ficolins but show different structures and specificities. In L‐ficolin, three additional binding sites (S2–S4) surround the cleft. Together, they define an unpredicted continuous recognition surface able to sense various acetylated and neutral carbohydrate markers in the context of extended polysaccharides such as 1,3‐β‐d‐glucan, as found on microbial or apoptotic surfaces.